USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Sealite Sciences, Inc.
Address: 3000 N WOODS PKY, STE 200
Norcross, GA 30071
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $452,476.00 6
SBIR Phase II $468,906.00 1

Award List:

LUMINESCENCE DETECTION REAGENTS FOR GLYCOLIPIDS

Award Year / Program / Phase: 1989 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00

LUMINESCENCE DETECTION REAGENTS FOR GLYCOLIPIDS

Award Year / Program / Phase: 1991 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $468,906.00
Abstract:
Alterations in surface carbohydrates in glycolipids and glycoproteins of tumor cells relative to normal cells is a common feature of malignant diseases. immunostaining procedures developed for detecting glycolipid antigens with tumor-specific antibodies represent important new techniquesfor… More

GLYCOSYLATION STATUS ASSAYS FOR DIAGNOSTIC TUMOR MARKERS

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: David F Smith
Award Amount: $49,997.00
Abstract:
Certain serum glycoproteins that are elevated in the serum or urine of cancer patients are considered to be tumro markers. analyses of the oligosaccharide side-chains on many of these glycoproteins, including a-fetorprotein (afp), gamma-glutamyltranspeptidase and human chronic gonadotropin, which… More

Bioluminescent Immunoassay for Testosterone

Award Year / Program / Phase: 1994 / SBIR / Phase I
Agency: HHS
Principal Investigator: Charles Rigl
Award Amount: $74,644.00
Abstract:
Radioimmunoassays make up a significant percentage of the immunoassays used in clinicallaboratories. Nonradioactive, immunometric or "sandwich" assays using enzymes for signal generation(EIAs) have generally replaced radioimmunoassays for high molecular weight analytes. Low molecularweight analytes… More

Bioluminescent Detection of Mycobacterium Tuberculosis

Award Year / Program / Phase: 1995 / SBIR / Phase I
Agency: HHS
Principal Investigator: David Smith
Award Amount: $85,491.00
Abstract:
Mycobacterial tuberculosis (MTB) has recently reemerged as the leading infectious disease in the wobecause of HIV, drug use, homelessness and poverty. Current diagnostics for MTB are slow and laboriotreatment is effective when administered early. Thus, rapid methods for speculation and detection… More

Cryptosporidosis--A Bioluminescent Cryptosporidium Assay

Award Year / Program / Phase: 1995 / SBIR / Phase I
Agency: HHS
Principal Investigator: David Smith
Award Amount: $92,972.00
Abstract:
There has been a recent concern raised regarding the contamination of water supplies by CryptosporiThis was sparked by the outbreak that occurred in Milwaukee. While contamination by any microbial agCryptosporidium has received much attention, in part, because it is a problem for… More

BIOLUMINESCENT ASSAY FOR QUANTIFYING PCR PRODUCTS

Award Year / Program / Phase: 1996 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $99,372.00